Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | P3 - Poster Session 3

Saturday 04/02/22
05:30 PM - 06:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Sleep, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Practice, Policy, and Ethics
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM PDT Abstract 9-001 - Baseline Characteristics and Demographics of Patients Enrolled in an Expanded Access Program for Efgartigimod in Adult Patients with Generalized Myasthenia Gravis
Deborah Gelinas, MD
05:30 PM - 06:30 PM PDT Abstract 9-002 - Pharmacokinetics and Pharmacodynamics of Ravulizumab in Adults with Generalized Myasthenia Gravis: Results from the Phase 3 CHAMPION MG Study
Tuan H. Vu, MD
05:30 PM - 06:30 PM PDT Abstract 9-003 - Safety of different IVIG doses for treatment of CIDP. The ProCID study
Elisabeth Clodi, PhD
05:30 PM - 06:30 PM PDT Abstract 9-004 - The ProDERM study: Safety and Tolerability Results from randomized, double-blind, placebo-controlled Phase-III-Trial in Patients with Dermatomyositis.
Rohit Aggarwal, MD
05:30 PM - 06:30 PM PDT Abstract 9-005 - Missed Opportunities to Prevent N-methyl-D-aspartate Receptor (NMDAR) Encephalitis in a DREAMer
Paul D. Crane, MD
05:30 PM - 06:30 PM PDT Abstract 9-006 - A case of a 4-year-old female with Leucine Rich Glioma Inactivated protein (LGI1) encephalitis associated with a cystic nephroma, responsive to intravenous immunoglobulin (IVIG), corticosteroids, and rituximab
Brandon C. Neeley, MD
05:30 PM - 06:30 PM PDT Abstract 15-001 - Evaluation of the Long-Term Safety and Tolerability of Oral Atogepant 60 Mg Once Daily for Preventive Treatment of Migraine: A Phase 3, 40-Week, Multicenter Extension to the Advance Trial
Brad C. Klein, MD, MBA, FAAN
05:30 PM - 06:30 PM PDT Abstract 15-002 - ALLEVIATE, a Clinical Trial-in-Progress of Eptinezumab in Patients With Episodic Cluster Headache
Elin Lof, PhD
05:30 PM - 06:30 PM PDT Abstract 15-003 - Changes in Heart Rate and Blood Pressure in Participants Treated With Fremanezumab for Migraine: A Pooled Analysis of Phase 3 Studies
Simi Negi, PhD
05:30 PM - 06:30 PM PDT Abstract 15-004 - Efficacy and Disability Outcomes of Fremanezumab in Patients With Prior OnabotulinumtoxinA Treatment Failure: Pooled Results of 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies
Juliana VanderPluym, MD
05:30 PM - 06:30 PM PDT Abstract 15-005 - Long-term Safety and Tolerability of Erenumab In Episodic Migraine: A Pooled Analysis From Two Clinical Trials and Their Extension Phases
Peter Goadsby, MD, PhD, FRS
05:30 PM - 06:30 PM PDT Abstract 15-006 - Optimization of Acute Treatment and Headache-Related Impact Following Eptinezumab Initiated During a Migraine Attack: Post Hoc Analysis of the RELIEF Study
Anders Ettrup
05:30 PM - 06:30 PM PDT Abstract 3-001 - Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study
Ding-Ding Zhang
05:30 PM - 06:30 PM PDT Abstract 3-002 - COVID-19 case fatality and Alzheimer’s disease
Qiang J. Zhang, MD
05:30 PM - 06:30 PM PDT Abstract 3-003 - Simple risk scores for the prediction of brain ß-amyloid and tau status in older adults with mild cognitive impairment
Ali Ezzati, MD
05:30 PM - 06:30 PM PDT Abstract 3-004 - High Sensitivity Simoa Immunoassays to Evaluate Levels of Postsynaptic density protein 95 and Neuronal Pentraxin II as Predictors of Cognitive Function Loss in Alzheimer’s Diseases
05:30 PM - 06:30 PM PDT Abstract 3-005 - An Ultrasensitive Immunoassay for the Detection of p-tau231 in Plasma, Serum & CSF
Valerie Brachet, PhD
05:30 PM - 06:30 PM PDT Abstract 12-001 - Sick leave and occupational burnout among nurse practitioners caring for patients with multiple sclerosis
Gustavo Saposnik, MD
05:30 PM - 06:30 PM PDT Abstract 12-002 - Small Fiber Neuropathy in Multiple Sclerosis: A Case Series
Natalie K. Erlich-Malona, MD
05:30 PM - 06:30 PM PDT Abstract 12-003 - Retrospective Evaluation of De-Escalation from Anti-CD20 Therapies to Fumarates as a Treatment Approach
Enrique Alvarez, MD, PhD
05:30 PM - 06:30 PM PDT Abstract 12-004 - Risk Perception in Multiple Sclerosis: Reasons for Switching Treatment Between High Efficacy and Non-high Efficacy Disease-modifying Therapies
Gustavo Seifer, Prof
05:30 PM - 06:30 PM PDT Abstract 12-005 - Dimethyl Fumarate Demonstrates Treatment Effectiveness in Patients One Year After Switching From Teriflunomide
Sai L. Shankar, PhD, FAAN
05:30 PM - 06:30 PM PDT Abstract 12-006 - The Role of Human and Mouse BTK in Myeloid Cells
Danielle Harlow
05:30 PM - 06:30 PM PDT Abstract 12-007 - Autoantibodies to an RNA binding protein exacerbate clinical disability and neurodegeneration in an in vivo model of multiple sclerosis
Cole D. Libner
05:30 PM - 06:30 PM PDT Abstract 12-008 - Disruption of Stem Cell Proliferation and Differentiation Capacity in a Cerebral Organoid Model of Multiple Sclerosis
Mia DiCostanzo
05:30 PM - 06:30 PM PDT Abstract 12-010 - Quantitative Analysis of Wild Type (WT) and Shiverer (SHR) Mouse Spinal Cords using Ultrahigh-b DWI (UHb-DWI)
Kyle E. Jeong, PhD
05:30 PM - 06:30 PM PDT Abstract 12-011 - Thyromimetics improve disease endpoints and modulate potential target engagement biomarkers in rodent models of ALD and MS
Michaelanne B. Woerner, PhD
05:30 PM - 06:30 PM PDT Abstract 6-001 - Effects of sulfatide accumulation on peripheral nerves in metachromatic leukodystrophy
Christian Krarup, MD, DMSc, FRcP, FAAN
05:30 PM - 06:30 PM PDT Abstract 6-002 - Increased Anxiety, Depression and Suicidal Ideation in Children with Neuromyelitis Optica
Margaret Codispoti
05:30 PM - 06:30 PM PDT Abstract 6-003 - Tic Severity and Family Function in Children with Tourette Syndrome and Coprophenomena
Samantha P. Myers
05:30 PM - 06:30 PM PDT Abstract 6-004 - Pediatric Functional Neurological Disorder: Investigating Demographic & Clinical Factors and Impacts on Management
Ria Pal, MD
05:30 PM - 06:30 PM PDT Abstract 6-005 - Non Decussating Retinal-fugal Fiber Achiasmatic Syndrome, Expanding The Clinical and Radiological Features of an Exceedingly Rare Cause of Congenital Nystagmus, a Report of Additional Three Patients and a Review
Abdulhafeez Khair, MD
05:30 PM - 06:30 PM PDT Abstract 7-001 - Network Localization of Visual Anosognosia from 28 Cases of Anton Syndrome
Kyla A. Gaudet
05:30 PM - 06:30 PM PDT Abstract 7-002 - Discourse Comprehension in Healthy Adults and Individuals with Acute Aphasia: an fNIRS Study
Hana Kim, PhD
05:30 PM - 06:30 PM PDT Abstract 7-003 - Volumetric Brain MRI Quantification in Early versus Late Onset Alzheimer’s Disease
Somayeh Meysami, MD
05:30 PM - 06:30 PM PDT Abstract 7-004 - In Response to Social Acceptance, Nucleus Accumbens Mu Opioid Receptor Activation is Associated with Increased Self-Esteem and Positive Mood
Kathryn Hill
05:30 PM - 06:30 PM PDT Abstract 7-005 - Clinical Features and Neuroimaging of Anomic Progressive Aphasia
Christine Cliatt Brown, MD
05:30 PM - 06:30 PM PDT Abstract 1-001 - Real-World Resource Utilization and Productivity Loss among Patients with Myasthenia Gravis in Sweden: A Nationwide Population-based Study
Qiaoyi Zhang, MD, PhD
05:30 PM - 06:30 PM PDT Abstract 1-002 - Brain Dead or Alive: Pitfalls in Neurological Prognostication
Danielle Bazer, DO
05:30 PM - 06:30 PM PDT Abstract 1-003 - Defining and Understanding Barriers to Medication Reconciliation in the Outpatient Neurology Clinic
Alex J. Luke, MD
05:30 PM - 06:30 PM PDT Abstract 1-004 - Seizure Alert: An Interdisciplinary Protocol for Timely Anti-Seizure Medication Administration in the Setting of Status Epilepticus
Kelly L. Block, DO
05:30 PM - 06:30 PM PDT Abstract 1-005 - The Effect of Sleep Disordered Breathing on Cognitive Function in Patients with Normal Pressure Hydrocephalus
05:30 PM - 06:30 PM PDT Abstract 10-001 - Safety Profiles of Second-Generation Antiseizure Medications: A Pharmacovigilance Study
Mokshal Porwal
05:30 PM - 06:30 PM PDT Abstract 10-002 - Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis
Nayana Prabhu, MD
05:30 PM - 06:30 PM PDT Abstract 10-003 - Antiseizure drugs adherence in elderly patients with epilepsy
05:30 PM - 06:30 PM PDT Abstract 10-004 - Atypical Presentation of Lance Adams Syndrome in the setting of Clonazepam overdose and SARS-CoV-2 pneumonia
Luis A. Cruz-Saavedra, MD
05:30 PM - 06:30 PM PDT Abstract 10-006 - New-Onset Refractory Status Epilepticus After Pfizer-BioNTech COVID-19 Vaccination
Kristie Bauman, MD
05:30 PM - 06:30 PM PDT Abstract 4-001 - Epochs Of Sternutation Induced By Coronavirus 19
Sunjeet Brar
05:30 PM - 06:30 PM PDT Abstract 4-002 - Covid-19 Associated Extreme Fatigue Effects on Activities of Daily Living in Mild and Long-Haul Infections: Patient Perspectives from a Remote Patient Monitoring Program
05:30 PM - 06:30 PM PDT Abstract 4-004 - Machine learning approaches for automated segmentation of gliomas
Niklas J. Tillmanns
05:30 PM - 06:30 PM PDT Abstract 4-005 - Quality Improvement Project: Number of Neurofibromatosis Type I Patients with Unidentified Bright Objects (UBOs) on MRI that Developed Subsequent Gliomas
Mekka R. Garcia, MD
05:30 PM - 06:30 PM PDT Abstract 13-001 - Loeffler’s endocarditis: A rare cause of stroke resulting in person in the barrel syndrome
Maya Gabel, MD
05:30 PM - 06:30 PM PDT Abstract 13-002 - Recurrent Ischemic Strokes in Biliary tract malignancy: Role of Direct-Acting Oral Anticoagulants and Early Screening – Case Series
Noor Mahmoud, MD
05:30 PM - 06:30 PM PDT Abstract 13-003 - A Case of Hemichorea-Hemiballism Following a Cortical Stroke from Occlusion of an Anomalous Accessory Middle Cerebral Artery
Priyanka Moondra, DO
05:30 PM - 06:30 PM PDT Abstract 13-004 - Knot so Straight Forward: A Rare Case of Mixed Pial-Dural Arteriovenous Malformation combined with an Arteriovenous Fistula of the Posterior Circulation
Maria G. Martucci, MD
05:30 PM - 06:30 PM PDT Abstract 13-005 - Cervico-Thoracic Spinal Dural Arteriovenous Fistula in a Patient with Lower Extremity Weakness Exacerbated by Steroids and Lumbar Puncture
Sukhraj Gill, MD
05:30 PM - 06:30 PM PDT Abstract 13-006 - Ocular lateral deviation as a clinical sign of medial PICA infarct
Nicole Platti, MD
05:30 PM - 06:30 PM PDT Abstract 13-007 - A Rare Case of Adult Onset Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes at Age 60
Adriana C. Mendez, MD
05:30 PM - 06:30 PM PDT Abstract 13-008 - Subarachnoid Hemorrhage Secondary to An Exceedingly Rare Case of STELARA® (Ustekinumab) Induced Reversible Cerebral Vasoconstrictive Syndrome
Michael Hadler, DO
05:30 PM - 06:30 PM PDT Abstract 13-009 - Pulmonary Arteriovenous Malformation (PAVM): An Uncommon Cause of Cryptogenic and Embolic Stroke of Undetermined Source (ESUS).
Farah Y. Fourcand, MD
05:30 PM - 06:30 PM PDT Abstract 13-010 - Short Term Acute Ischemic Stroke after Initiation of Gender-Affirming Hormone Therapy: A Case Report
Ricardo Murguia Fuentes, MD
05:30 PM - 06:30 PM PDT Abstract 5-001 - Young-Onset Huntington's Disease: Defining an Emerging Clinical Cohort
Miguel A. Ruvalcaba, MD
05:30 PM - 06:30 PM PDT Abstract 5-003 - Patient Experiences in early Huntington’s Disease - Qualitative Research to Inform Development of a Patient-Reported Instrument of Everyday Functioning
05:30 PM - 06:30 PM PDT Abstract 5-004 - The Association Between Lifestyle Factors and Huntington´s Disease Mortality
Esther Cubo Delgado, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 5-005 - Psychometric Validation of Huntington’s Disease Everyday Functioning (Hi-DEF) Scale –Study Design and Sample Characteristics
05:30 PM - 06:30 PM PDT Abstract 5-006 - A Sentiment Analysis of Unstructured Electronic Medical Record Data of Patients Treated With Vesicular Monoamine Transporter 2 Inhibitors in Huntington’s Disease and Tardive Dyskinesia
Sam Leo, PharmD
05:30 PM - 06:30 PM PDT Abstract 5-007 - Clinical evidence that treatment with pepinemab, a novel regulator of neuroinflammation, provides cognitive benefit to patients with Huntington’s and potentially other neurodegenerative diseases
Elizabeth E. Evans, PhD
05:30 PM - 06:30 PM PDT Abstract 2-001 - Pontine Cavernous Hemangioma As a Possible Cause of New Onset Seizures and Millard-Gubler Syndrome in a Middle aged Female
Dylan Weaver
05:30 PM - 06:30 PM PDT Abstract 2-002 - No More Tissue: Elimination of Sneezing Due To Cerebellar Hemorrhage
Ashmeet S. Sahni, MD
05:30 PM - 06:30 PM PDT Abstract 2-003 - Transient Opening of the Blood-Brain Barrier by Vasoactive Peptides to Increase CNS Drug Delivery:  Reality versus Wishful Thinking?
Matthew Smith-Cohn, DO
05:30 PM - 06:30 PM PDT Abstract 11-001 - Clinical utility and feasibility of an ALS specific advance care directive: A retrospective chart review
Tyra Swanson
05:30 PM - 06:30 PM PDT Abstract 11-002 - ALS and cerebellum: Study of Eyeblink conditioning in Subjects with ALS
Aiga Rakhesh, MD
05:30 PM - 06:30 PM PDT Abstract 11-003 - Edaravone in The Disease Course of ALS Effect. Retrospective Trial
05:30 PM - 06:30 PM PDT Abstract 11-004 - Evaluation of Gastrointestinal Symptoms in an ALS Cohort
Rizamarie Empeno, MD
05:30 PM - 06:30 PM PDT Abstract 11-005 - An Open Label Study of Poly-MVA to Treat Fatigue in ALS
Amer Avdagic
05:30 PM - 06:30 PM PDT Abstract 11-006 - Degeneration of upper and lower motor neurons in a novel CSF-mediated animal model of sporadic ALS
Rose P. Griffin
05:30 PM - 06:30 PM PDT Abstract 11-007 - COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry NCT04559009
Urvi G. Desai, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 11-008 - Adipose Tissue Distribution as a Predictor of Rate of Progression in Patients with Amyotrophic Lateral Sclerosis
Gracia Luoma-Overstreet, BS
05:30 PM - 06:30 PM PDT Abstract 11-009 - Barriers and facilitators to continuing non-invasive ventilation use in individuals with amyotrophic lateral sclerosis
Jennifer L. Marsella, MD
05:30 PM - 06:30 PM PDT Abstract 11-010 - RACK1 Knockdown Alleviates TDP-43-Associated Global Translational Suppression in vitro, and Neurodegeneration in vivo
Beibei Zhao
Faculty Disclosures
No disclosure on file
Maria Diez-Cirarda No disclosure on file
Sunjeet Brar Miss Brar has nothing to disclose.
Gabriel Rodriguez Gabriel Rodriguez has nothing to disclose.
Zheng-Yu Jin No disclosure on file
Valerie Brachet, PhD Dr. Brachet has received personal compensation for serving as an employee of Quanterix . Dr. Brachet has stock in Quanterix.
Georgina M. Aldridge, MD, PhD Dr. Aldridge has nothing to disclose.
Emma Reford Ms. Reford has nothing to disclose.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurene. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tremeau. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from Celgene. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Director with American Migraine Foundation that is relevant to AAN interests or activities.
John Furey Mr. Furey has nothing to disclose.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Rohan Gandhi, PhD Dr. Gandhi has received personal compensation for serving as an employee of Autobahn Therapeutics. Dr. Gandhi has stock in Autobahn Therapeutics.
Johanne M. Kaplan, PhD Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Sisira Yadala, MD, FAAN Dr. Yadala has nothing to disclose.
Danielle Bazer, DO Dr. Bazer has nothing to disclose.
Ritesh Ramdhani, MD Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accorda. Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance.
Aaron Koenig Aaron Koenig has received personal compensation for serving as an employee of Sage Therapeutics.
Salman Zahoor, MBBS Dr. Zahoor has nothing to disclose.
Alan R. Hirsch, MD, FACP Dr. Hirsch has nothing to disclose.
Ruta Sawant, PhD Ms. Sawant has received personal compensation for serving as an employee of Sage Therapeutics. Ms. Sawant has received stock or an ownership interest from Sage Therapeutics.
Li-Ying Cui No disclosure on file
Brandi L. Vollmer, MPH Ms. Vollmer has nothing to disclose.
Stefan Cano, MD Stefan Cano, MD has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Modus Outcomes. Stefan Cano, MD has received stock or an ownership interest from Modus Outcomes. Stefan Cano, MD has received intellectual property interests from a discovery or technology relating to health care.
Nicolas Medrano, MD Dr. Medrano has nothing to disclose.
Hannah Carlson Mrs. Carlson has nothing to disclose.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Alfred Balasa, MD Dr. Balasa has nothing to disclose.
Natalie K. Erlich-Malona, MD Dr. Erlich-Malona has nothing to disclose.
Christine I. Dali, MD Dr. Dali has received personal compensation for serving as an employee of Orphazyme A/S .
Phoebe Jiang, PhD Dr. Jiang has received personal compensation for serving as an employee of Biogen. Dr. Jiang has stock in Biogen.
Kyle E. Jeong, PhD Dr. Jeong has nothing to disclose.
Stephen Falchek, MD Dr. Falchek has nothing to disclose.
Nicolas Daviaud, PhD Nicolas Daviaud has nothing to disclose.
Gianvito Martino, MD Dr. Martino has nothing to disclose.
Stuart A. Grossman, MD Stuart A. Grossman, MD has stock in Myosin Therapeutics Inc. The institution of Stuart A. Grossman, MD has received research support from National Cancer Institute. Stuart A. Grossman, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Member, Brain Malignancy Steering Committee with National Cancer Institute.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Shu-Yang Zhang No disclosure on file
Matthew Orwitz, MD Dr. Orwitz has nothing to disclose.
Jonathan Rosenthal, MD Dr. Rosenthal has nothing to disclose.
Binod Wagle, MD, FAAN Dr. Wagle has nothing to disclose.
Gracia Luoma-Overstreet, BS Ms. Luoma-Overstreet has received research support from National Institutes of Health.
Noor Mahmoud, MD Dr. Mahmoud has nothing to disclose.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Cecilia Quarracino Benchetrit, MD Mrs. Quarracino Benchetrit has nothing to disclose.
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Somayeh Meysami, MD Dr. Meysami has nothing to disclose.
Saima Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Adriana C. Mendez, MD Dr. Mendez has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Vishal Gupta, DO Dr. Gupta has nothing to disclose.
Elisabeth Clodi, PhD Dr. Clodi has received personal compensation for serving as an employee of Octapharma Pharmazeutika Produktionsges.m.b.H..
Seth N. Levin, MD Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen.
Kelly L. Block, DO Dr. Block has nothing to disclose.
Evan Riddle, PhD Dr. Riddle has received personal compensation for serving as an employee of Biogen. Dr. Riddle has received stock or an ownership interest from Biogen.
Alvaro Garcia Bustillo No disclosure on file
Jeffrey M. Katz, MD Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Merle Diamond No disclosure on file
Martin Berghoff, MD, FAAN Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Qiang J. Zhang, MD The institution of Dr. Zhang has received research support from NIH/NIA.
Jessica Lin, MD Dr. Lin has nothing to disclose.
Tuan H. Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImmunAbs. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from Amylyx Pharma. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Annexon. The institution of Dr. Vu has received research support from Horizon. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Momenta. The institution of Dr. Vu has received research support from Immunovant.
Cole D. Libner Mr. Libner has received research support from Canadian Institutes of Health Research PhD Scholarship .
Elizabeth McQuade, MD Dr. McQuade has nothing to disclose.
Joanna J. Chang, MD Dr. Chang has nothing to disclose.
Hira Zafar, MBBS Dr. Zafar has nothing to disclose.
Claudia Vallin, DO Dr. Vallin has nothing to disclose.
Michael Hadler, DO Dr. Hadler has nothing to disclose.
Mahjabin Islam, MBBS, MRCP( UK ) Dr. Islam has nothing to disclose.
Kathleen Beasley, PharmD Dr. Beasley has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Beasley has received stock or an ownership interest from Alexion, AstraZeneca Rare Disease.
Zsuzsanna Bata-Csorgo No disclosure on file
Jamie Wong, PhD Dr. Wong has nothing to disclose.
Ashmeet S. Sahni, MD Dr. Sahni has nothing to disclose.
Sebastian Koch, MD Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
Kellen Petersen No disclosure on file
Suparna R. Krishnaiengar, MD Dr. Krishnaiengar has nothing to disclose.
Deema A. Fattal, MD An immediate family member of Dr. Fattal has received research support from American transportation center and DOD.
Marta Ruiz Lopez, MD Dr. Ruiz Lopez has nothing to disclose.
Maria M. Esnaola Y Rojas, MD Dr. Esnaola Y Rojas has nothing to disclose.
Maria G. Martucci, MD Dr. Martucci has nothing to disclose.
Nora R. Jandhyala, MD Ms. Jandhyala has nothing to disclose.
Mitchell Onken, MD Dr. Onken has nothing to disclose.
Abdullahi Musa Adamu, MBBS Dr. Adamu has nothing to disclose.
Nikita Shukla, MD The institution of Dr. Shukla has received research support from Roche.
Priyanka Moondra, DO Dr. Moondra has nothing to disclose.
Kendall Nichols, MD Dr. Nichols has nothing to disclose.
Beibei Zhao Beibei Zhao has received intellectual property interests from a discovery or technology relating to health care.
Elizabeth E. Evans, PhD Dr. Evans has received personal compensation for serving as an employee of Vaccinex. Dr. Evans has stock in Vaccinex. Dr. Evans has received intellectual property interests from a discovery or technology relating to health care.
Norman W. Barton, MD, PhD Dr. Barton has received personal compensation for serving as an employee of Takeda Pharmaceutical Co. LTD. Dr. Barton has received stock or an ownership interest from Takeda Pharmaceutical Co. LTD.
Christine Stadelmann-Nessler No disclosure on file
Nadia M. Celestin, BS Miss Celestin has nothing to disclose.
Michelle Finnegan Michelle Finnegan has received personal compensation for serving as an employee of AbbVie.
Todd Nguyen, MD Mr. Nguyen has nothing to disclose.
Pooja Gandhi Pooja Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals. Pooja Gandhi has stock in Teva Pharmaceuticals.
Praveen Ramani, MBBS Dr. Ramani has nothing to disclose.
Rohit Aggarwal, MD Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.
Isaiah Kletenik, MD The institution of Dr. Kletenik has received research support from NIH.
Natalia Romano Spica Ms. Romano Spica has nothing to disclose.
Sara A. McGuire, MD Dr. McGuire has nothing to disclose.
Ajay Malhotra No disclosure on file
Cynthia Gibson, NP Ms. Gibson has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylx.
Sandeep Gill, MD Dr. Gill has nothing to disclose.
Kaleb H. Yohay, MD Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Matthew Smith-Cohn, DO Dr. Smith-Cohn has nothing to disclose.
Urvi G. Desai, MD, FAAN Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Qiaoyi Zhang, MD, PhD Dr. Zhang has received personal compensation for serving as an employee of Janssen. Dr. Zhang has stock in Janssen.
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Inigo G. Cuellar Inigo Gabilondo Cuellar has nothing to disclose.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1 Capital, LLC. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cello Health BioConsulting, previously Defined Health. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RAF-5. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Houston NeuroCare. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Dr. Dimachkie has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RaPharma/UCB. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SCHOLAR Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jenssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amazentis / Vandria. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANEM. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme . Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Covance / Labcorp. The institution of Dr. Dimachkie has received research support from CSL Behring. The institution of Dr. Dimachkie has received research support from Orphazyme. The institution of Dr. Dimachkie has received research support from FDA-OOPD. The institution of Dr. Dimachkie has received research support from NIH. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Jonathan Cahill, MD, FAAN The institution of Dr. Cahill has received research support from Roche / Genentech. Dr. Cahill has received publishing royalties from a publication relating to health care.
Dylan Weaver Mr. Weaver has nothing to disclose.
Ali Ezzati, MD Dr. Ezzati has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mist Research. Dr. Ezzati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioDelivery Sciences International (BDSI) . The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Maya Gabel, MD Dr. Gabel has nothing to disclose.
Sam Leo, PharmD Dr. Leo has received personal compensation for serving as an employee of Teva Pharmaceutical Industries.
Neil R. Cashman, MD Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care. Dr. Cashman has a non-compensated relationship as a BoD memeber with ALS Society of BC that is relevant to AAN interests or activities.
Michael D. Fox, MD, PhD Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Luis A. Sierra, Jr. Mr. Sierra has nothing to disclose.
Sukhraj Gill, MD Dr. Gill has nothing to disclose.
Zihuai He No disclosure on file
Guillermo Bueno Mr. Bueno has received personal compensation for serving as an employee of Roche .
Andrew S. Feigin, MD Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Matthew Jensen, MD Dr. Jensen has nothing to disclose.
Matthew Hart, MD Dr. Hart has nothing to disclose.
Jun Ni No disclosure on file
Henry P. Moore, MD Dr. Moore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie . Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC.
Brandon C. Neeley, MD Dr. Neeley has nothing to disclose.
Esther Cubo Delgado, MD, FAAN Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samus. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylym. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics.
Syed Rizvi, MD Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na.
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has stock in CND Life Sciences. Dr. Levine has stock in Corinthian reference lab.
Michael J. Marmura, MD, FAAN Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Marmura has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Marmura has stock in Curelator. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Deborah Gelinas, MD Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx.
Abdulhafeez Khair, MD Dr. Khair has nothing to disclose.
Faddi G. Saleh Velez, MD Dr. Saleh Velez has nothing to disclose.
Kaancan Deniz, MD Dr. Deniz has nothing to disclose.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Beatriz Tijero, PhD The institution of Dr. Tijero has received research support from Gobierno vadcon.
Joan Maley No disclosure on file
Christine Cliatt Brown, MD Dr. Cliatt Brown has nothing to disclose.
Elin Lof, PhD Dr. Lof has nothing to disclose.
Laszlo Mechtler, MD, FASN, FAAN Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jushi Inc. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mechtler has received stock or an ownership interest from Jushi Co.. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Amgen/Novartis. The institution of Dr. Mechtler has received research support from Alder/ Lundbeck. The institution of Dr. Mechtler has received research support from Abbvie/Allergan. The institution of Dr. Mechtler has received research support from Miles for Migraine. The institution of Dr. Mechtler has received research support from American Migraine Foundation. The institution of Dr. Mechtler has received research support from Charlotte's Web.
Kyla A. Gaudet Ms. Gaudet has nothing to disclose.
Sara Strauss, DO Dr. Strauss has nothing to disclose.
Deidre MacKenna, PhD Deidre MacKenna has received personal compensation for serving as an employee of Autobahn Therapeutics. Deidre MacKenna has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for PharmAkea Therapeutics. Deidre MacKenna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regulus Therapeutics. Deidre MacKenna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pacific Rim Pathology. Deidre MacKenna has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Phenex Inc. Deidre MacKenna has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Blade Therapeutics. Deidre MacKenna has received stock or an ownership interest from Autobahn Therapeutics. Deidre MacKenna has received stock or an ownership interest from Blade Therapeutics.
Fei Han No disclosure on file
Mariam Aboian, MD, PhD Dr. Aboian has a non-compensated relationship as a Principal Investigator with Visage Imaging that is relevant to AAN interests or activities.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory.
Rainel Sanchez-De La Rosa, MD, PhD No disclosure on file
Wentao Li, MD Dr. Li has nothing to disclose.
Monica Kim, DO Miss Kim has nothing to disclose.
Lynda Krasenbaum Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Kathryn Hill Ms. Hill has nothing to disclose.
Ryan C. Corn, DO Dr. Corn has nothing to disclose.
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for arenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ra Pharma (now UCB Biosciences). Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Laboratories. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape CME. Dr. Howard has stock in General Electric dividends. Dr. Howard has stock in Johnson & Johnson dividends. Dr. Howard has stock in Pfizer dividends. An immediate family member of Dr. Howard has stock in GlaxoSmithKline dividends. An immediate family member of Dr. Howard has stock in GE Healthcare dividends. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Duke University (DCRI). The institution of Dr. Howard has received research support from Cartestian Therapeutics. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Alex J. Luke, MD Dr. Luke has nothing to disclose.
Benjamin Van Hoorick No disclosure on file
Jason Mendoza No disclosure on file
Nicholas Koroneos, DO Dr. Koroneos has nothing to disclose.
Victor J. Del Brutto, MD The institution of Dr. Del Brutto has received research support from Florida Health Department. The institution of Dr. Del Brutto has received research support from american heart association.
Rizamarie Empeno, MD Dr. Empeno has nothing to disclose.
Rajeev Kumar, MD, FRCPC The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Pharma. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from Pharma Two B. The institution of Dr. Kumar has received research support from Enterin. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC.
Michal Obrzut No disclosure on file
Stephan Ortiz, PhD Dr. Ortiz has received personal compensation for serving as an employee of Alexion/AstraZeneca Rare Disease. Dr. Ortiz has stock in Alexion.
Susan L. Perlman, MD Dr. Perlman has nothing to disclose.
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care.
Eddie Jones, BA Eddie Jones, BA has nothing to disclose.
Muhammed Ikbal Arvas, MD Dr. Arvas has nothing to disclose.
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Lisa D. Bunker, PhD, CCC-SLP Dr. Bunker has received research support from NIH.
Juan Carlos Gomez Esteban, MD Dr. Gomez Esteban has nothing to disclose.
Tyra Swanson Miss Swanson has nothing to disclose.
Ding-Ding Zhang No disclosure on file
Yuan Cao Ms. Cao has nothing to disclose.
Tara Edwards Miss Edwards has nothing to disclose.
Sam Payabvash No disclosure on file
Tamra I. Ranasinghe, MD Dr. Ranasinghe has nothing to disclose.
Jennifer A. Vermilion, MD The institution of Dr. Vermilion has received research support from Tourette Association of America, American Academy of Neurology and American Brain Foundation. The institution of Dr. Vermilion has received research support from Centers for Disease Control.
Ingemar S. Merkies, MD No disclosure on file
Luis A. Cruz-Saavedra, MD Dr. Cruz-Saavedra has nothing to disclose.
Azima Shaji, MD, MBBS Dr. Shaji has nothing to disclose.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Neli Boneva No disclosure on file
Joseph Duffy No disclosure on file
Schweta P. Rane, MBBS Dr. Rane has nothing to disclose.
Busranur Agac, MD Dr. Agac has nothing to disclose.
Samantha P. Myers Ms. Myers has nothing to disclose.
Hua Guo, PhD Hua Guo has received personal compensation for serving as an employee of AbbVie. Hua Guo has received stock or an ownership interest from AbbVie.
Siddhart K. Mehta, MD Dr. Mehta has nothing to disclose.
Mekka R. Garcia, MD Dr. Garcia has nothing to disclose.
Sruthi Devarinti, DO Dr. Devarinti has nothing to disclose.
Nicole Platti, MD Mrs. Platti has nothing to disclose.
Erika S. Horta, MD Dr. Horta has nothing to disclose.
Kara Stavros, MD, FAAN Dr. Stavros has nothing to disclose.
Jana Wold, MD Dr. Wold has nothing to disclose.
Danny Bega, MD Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN / ANA. The institution of Dr. Bega has received research support from Huntington Disease Society of America. The institution of Dr. Bega has received research support from Parkinson Foundation.
Sara Habib, MD, MBBS Dr. Habib has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Ivy Gao Miss Gao has nothing to disclose.
Aiga Rakhesh, MD Dr. Rakhesh has nothing to disclose.
Alexandra O. Duffy, MD, FAAN Dr. Duffy has nothing to disclose.
Hans D. Katzberg, MD, FAAN An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Christopher J. Campos, DO Dr. Campos has nothing to disclose.
Nayana Prabhu, MD Dr. Prabhu has nothing to disclose.
Rigmor Jensen No disclosure on file
Luca Muzio, PhD Dr. Muzio has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for retromer therapeutics. Dr. Muzio has received intellectual property interests from a discovery or technology relating to health care.
Gustavo Seifer, Prof Gustavo Seifer, Prof has received personal compensation for serving as an employee of Novartis.
Miriam Turuelo Miss Turuelo has nothing to disclose.
Cynthia Campen, MD Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Campen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms. The institution of Dr. Campen has received research support from Greathouse Family Foundation.
Rose P. Griffin Ms. Griffin has nothing to disclose.
Christian Krarup, MD, DMSc, FRcP, FAAN Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Paul Boon, MD, PhD, FEAN Dr. Boon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Boon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Livanova.
Lauren C. Skalomenos, MD Dr. Skalomenos has nothing to disclose.
Peter J. McAllister, MD, FAAN Dr. McAllister has received personal compensation for serving as an employee of Revance. Dr. McAllister has received personal compensation for serving as an employee of AbbVie. Dr. McAllister has received personal compensation for serving as an employee of Merz. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for teva. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biohaven. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Tejas R. Mehta, MD Dr. Mehta has nothing to disclose.
Prabandh R. Buchhanolla, MBBS Dr. Buchhanolla has nothing to disclose.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Kathryn Giles Kathryn Giles has stock in Synderdisc. The institution of Kathryn Giles has received research support from Biogen.
Amer Avdagic Mr. Avdagic has nothing to disclose.
Jennifer W. McVige, MD Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to AAN interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to AAN interests or activities.
Victoria M. Rice, DO Dr. Rice has nothing to disclose.
Cyrus A. Raji, MD, PhD Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Messoud Ashina, MD, PhD Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Mariana Bendersky Dr. Bendersky has received research support from Buenos Aires University .
Natalia Bohorquez Morera Natalia Bohorquez Morera has nothing to disclose.
Lauren A. Terpak, MD Dr. Terpak has nothing to disclose.
Nandakumar Narayanan, MD, PhD Dr. Narayanan has nothing to disclose.
Emma Ciafaloni, MD, FAAN Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Roland Grenningloh Roland Grenningloh has received personal compensation for serving as an employee of EMD Serono.
Hana Kim, PhD Dr. Kim has received research support from NIH.
Ria Pal, MD Dr. Pal has nothing to disclose.
Xiaoping Ning Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
Ursula Boschert Shafaatian Ursula Boschert has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
John Leonard No disclosure on file
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Philip Yeung, MD Dr. Yeung has nothing to disclose.
Ricardo Murguia Fuentes, MD Dr. Murguia Fuentes has nothing to disclose.
Farah Y. Fourcand, MD Dr. Fourcand has nothing to disclose.
Ming Yao No disclosure on file
Margaret Codispoti Ms. Codispoti has nothing to disclose.
Srikanth Karnati No disclosure on file
Heather Clark No disclosure on file
Uwe Reuter Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Liily Deutschland. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape . Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for StreaMEdUp. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Reuter has received research support from Novartis.
Amy Ogilvie, PhD Ms. Ogilvie has nothing to disclose.
Mia DiCostanzo Ms. DiCostanzo has nothing to disclose.
Jennifer L. Whitwell, PhD Dr. Whitwell has nothing to disclose.
Michaelanne B. Woerner, PhD Michaelanne Woerner has received personal compensation for serving as an employee of Autobahn Therapeutics. Michaelanne Woerner has stock in Autobahn Therapuetics.
Jee Bang, MD Dr. Bang has received personal compensation in the range of $0-$499 for serving as a Consultant for GLG. Dr. Bang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adept Field Solutions.
Argye E. Hillis, MD, MA Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
David R. Cornblath, MD Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Aruna S. Rao, MD No disclosure on file
Jonathan W. Mink, MD, PhD, FAAN The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Michelle Miranda No disclosure on file
Rami Fakih, MD Dr. Fakih has nothing to disclose.
Hugo Botha, MD Dr. Botha has received research support from NIH.
Mokshal Porwal Mr. Porwal has nothing to disclose.
Kaleb L. Culpepper, DO Dr. Culpepper has nothing to disclose.
Devorah Segal, MD Dr. Segal has nothing to disclose.
Vinothkumar Rajendran Mr. Rajendran has nothing to disclose.
Ranjithkumar Rajendran Mr. Rajendran has nothing to disclose.
Samuel J. Maiser, MD Dr. Maiser has nothing to disclose.
Mingli Li No disclosure on file
Shaun O. Smart, MD Dr. Smart has nothing to disclose.
Jennifer L. Marsella, MD Dr. Marsella has nothing to disclose.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
Richard A. Macdonell, MD, FAAN Dr. Macdonell has nothing to disclose.
Fei-Fei Zhai Fei-Fei Zhai has nothing to disclose.
Brad C. Klein, MD, MBA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biodelivery Science. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Omer W. Naveed, MD Dr. Naveed has nothing to disclose.
Debolina Kanjilal, MD Ms. Kanjilal has nothing to disclose.
Suzanne Liu, MD The institution of an immediate family member of Dr. Liu has received research support from NIH.
Chan Beals Chan Beals has received personal compensation for serving as an employee of Autobahn Therapeutics.
Qian Cai No disclosure on file
Paul D. Crane, MD Dr. Crane has nothing to disclose.
Rene Utianski No disclosure on file
Gustavo Saposnik, MD Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Eric R. Siemers, MD Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogstate Ltd. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. The institution of Dr. Siemers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for US Green Valley Pharmaceuticals, Inc. Dr. Siemers has stock in Acumen Pharmaceuticals. Dr. Siemers has stock in Ell Lilly and Company. Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Bright Focus Foundation that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Huntington Study Group that is relevant to AAN interests or activities.
Michael C. Levin, MD, FAAN Dr. Levin has received personal compensation for serving as an employee of Merck. Dr. Levin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Levin has received research support from CIHR.
Gisela Zanga Gisela Zanga has received publishing royalties from a publication relating to health care.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Miguel A. Ruvalcaba, MD Dr. Ruvalcaba has nothing to disclose.
Kristie Bauman, MD Dr. Bauman has nothing to disclose.
Joachim Schessl No disclosure on file
Verna R. Porter, MD Dr. Porter has nothing to disclose.
Teye A. Umanah, MD Dr. Umanah has nothing to disclose.
Xiang Fang, MD, PhD, FAAN Dr. Fang has nothing to disclose.
Victor W. Sung, MD Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure.
Anders Ettrup Anders Ettrup has received personal compensation for serving as an employee of H. Lundbeck A/S.
Pieter Van Doorn, MD The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunics. The institution of Dr. Van Doorn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Tracy E. Stites, PhD Dr. Stites has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Dr. Stites has received stock or an ownership interest from Novartis Pharmaceuticals.
Christina Charles-Schoeman No disclosure on file
Jessica K. Alexander, PhD Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Christopher P. Kellner, MD Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Joshua M. Cohen, MD No disclosure on file
Richard Libman, MD, FAAN Dr. Libman has nothing to disclose.
Rohan Arora, MD The institution of Dr. Arora has received research support from Bayer.
Saud A. Sadiq, MD, MB, FAAN Dr. Sadiq has nothing to disclose.
Simi Negi, PhD Dr. Negi has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Niklas J. Tillmanns Mr. Tillmanns has received research support from Heinrich Heine University Duesseldorf.
Juliana VanderPluym, MD Dr. VanderPluym has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports. The institution of Dr. VanderPluym has received research support from Amgen.
Danielle Harlow Danielle Harlow has received personal compensation for serving as an employee of EMD Serono, Inc..
Sai L. Shankar, PhD, FAAN Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has stock in Biogen.